EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of Smith–Lemli–Opitz Syndrome Carriers and the Spectrum of DHCR7 Pathogenic Variants in Representative Czech and Hungarian Population Cohorts

Eszter Kovács iD, Zsuzsanna Szűcs iD, Miroslav Horňák, David Kubíček, Kateřina Weisová, Kateřina Veselá, Lenka Krůzová, Jan Geryk, Jan Diblík iD, Martina Bittóová, Milan Macek iD, István Balogh iD und 1 weitere

Genes · 2026

DOI: 10.3390/genes17020164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Eszter Kovács und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Smith-Lemli-Opitz Syndrome, Oxidoreductases Acting on CH-CH Group Donors. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Ministry of Health, Czech Ministry of Youth Education and Sports, Czech Medical Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Smith–Lemli–Opitz syndrome (SLOS) is an inborn error of cholesterol biosynthesis, caused by biallelic mutations in the DHCR7 gene. Genotype–phenotype correlations regarding DHCR7 variants could explain the variation in severity, ranging from in utero demise or severe SLOS to a mild phenotype. Clinical recognition can be challenging. This study aimed to determine the frequency of SLOS carriers in the Central European population, as well as the mutational spectrum of DHCR7 in these carriers.

Methods

A retrospective analysis of DHCR7 variants was conducted using next-generation sequencing data from 55,289 individuals in Czech and Hungarian genetic laboratories.

Results

The SLOS carrier frequency and the mutational spectrum of the DHCR7 gene in its carriers were established in the Czech and Hungarian sub-cohorts. In the combined dataset, we identified causative DHCR7 variants on 1567 alleles among 55,289 tested individuals, contributing to an SLOS carrier frequency of 2.83%. Of the 31 DHCR7 variants detected, the c.452G>A variant was the most prevalent, accounting for 1.8% of all detected alleles in our cohorts. In contrast, the c.964-1G>C variant was more frequent in non-Finnish Europeans, as indicated by the gnomAD 4.1.0 database. The DHCR7 mutational spectra of patients and carriers were comparable in terms of the most common variants.

Conclusions

The high SLOS carrier frequency (2.83%) underscores the importance of SLOS carrier screening in Central European populations. The prevalent DHCR7 null mutations and their potential combinations may explain the lower-than-expected prevalence of SLOS, whilst Central and Eastern European populations remain likely underrepresented in the current gnomAD database.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smith-Lemli-Opitz SyndromeOxidoreductases Acting on CH-CH Group DonorsHumansCzech RepublicHungaryFemaleMutationPrevalenceHeterozygoteMaleGene FrequencyRetrospective StudiesAlleles

Stichwörter der Autor:innen

DHCR7SLOSSmith–Lemli–Opitz syndromecarrier frequency

Substanzen

7-dehydrocholesterol reductaseOxidoreductases Acting on CH-CH Group Donors

Autor:innen und Institutionen

  • Department of Medical Genetics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Doctoral School of Molecular Cell and Immune Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Repromeda, Assisted Reproduction Centre, 625 00 Brno, Czech Republic.
  • Department of Histology and Embryology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.
  • Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic.
  • Institute of Applied Biotechnologies a.s., 199 00 Prague, Czech Republic.

ORCID-Profile: Eszter Kovács, Zsuzsanna Szűcs, Jan Diblík, Milan Macek, István Balogh

Förderung

  • Czech Ministry of Health
  • Czech Ministry of Youth Education and Sports
  • Czech Medical Council
  • University of Debrecen Scientific Research Bridging Fund

Zitieren

APA

Kovács, E., Szűcs, Z., Horňák, M., Kubíček, D., Weisová, K., Veselá, K., Krůzová, L., Geryk, J., Diblík, J., Bittóová, M., Macek, M., Balogh, I., & Koczok, K. (2026). Prevalence of Smith–Lemli–Opitz Syndrome Carriers and the Spectrum of DHCR7 Pathogenic Variants in Representative Czech and Hungarian Population Cohorts. Genes. https://doi.org/10.3390/genes17020164

Vancouver

Kovács E, Szűcs Z, Horňák M, Kubíček D, Weisová K, Veselá K, et al. Prevalence of Smith–Lemli–Opitz Syndrome Carriers and the Spectrum of DHCR7 Pathogenic Variants in Representative Czech and Hungarian Population Cohorts. Genes. 2026. doi:10.3390/genes17020164

BibTeX
@article{Kovcs2026,
  author = {Kovács, Eszter and Szűcs, Zsuzsanna and Horňák, Miroslav and Kubíček, David and Weisová, Kateřina and Veselá, Kateřina and Krůzová, Lenka and Geryk, Jan and Diblík, Jan and Bittóová, Martina and Macek, Milan and Balogh, István and Koczok, Katalin},
  title = {Prevalence of Smith–Lemli–Opitz Syndrome Carriers and the Spectrum of DHCR7 Pathogenic Variants in Representative Czech and Hungarian Population Cohorts},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17020164}
}
Kostenlos starten →